Smiling Through Cancer Treatment Amid the COVID-19 Pandemic

November 26th 2020, 4:00pm

By Ryan McDonald

In this episode of the “CURE Talks Cancer” podcast, we spoke with a teenager who was diagnosed with Hodgkin lymphoma at the start of the COVID-19 pandemic. We talked about her cancer journey, what it was like to receive treatment during the pandemic, and more.

CURE’s Clinical Trial Corner: November 2020

November 26th 2020, 2:00pm

By Ryan McDonald

Here is a list of some recent trials that launched within the cancer space in November.

FDA Accelerates Approval of Danyelza for Children and Adults with Relapsed or Refractory High-Risk Neuroblastoma

November 25th 2020, 11:13pm

By Darlene Dobkowski, MA

The Food and Drug Administration’s approval of Danyelza comes as a result of two trials that assessed the efficacy of the drug in patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who did not have sufficient response to prior therapies.

First-Line Treatment with Additional Combination Therapy After Resection May Improve Survival for Pancreatic Cancer

November 25th 2020, 10:00pm

By Darlene Dobkowski, MA

This survival benefit was particularly observed in patients with node-positive disease, or cancer that spread to the lymph nodes according to pathology.

Theranostics 101: Combining Therapeutics and Diagnostics to Treat Prostate Cancer

November 25th 2020, 7:00pm

By Jessica Skarzynski

Theranostics, or the method of using one radioactive drug to diagnose a malignancy and a second radioactive drug to treat that cancer, is gaining in popularity in the treatment of prostate cancer.

Mammograms Feel Very Different to A Cancer Caregiver

November 25th 2020, 5:00pm

By Debbie Legault

In the wake of a cancer journey as a caregiver, mammogram appointments have a new meaning, and new emotions, associated with them than before.

Keytruda With an Androgen Receptor Modulator May Produce a Modest Benefit in Women with Androgen Receptor-Positive, Triple-Negative Breast Cancer

November 25th 2020, 4:00pm

By Darlene Dobkowski, MA

Despite a modest benefit in these patients, principal investigator Dr. Yuan Yuan said she is looking “forward to the future” with regards to therapies that integrate nonsteroidal selective androgen receptor modulators for this patient population.

Navigating Both Cancer and a Viral Pandemic Is a Difficult Balancing Act

November 25th 2020, 2:00pm

By Mike Hennessy Sr., Chairman

Living with cancer is not dissimilar to the challenges the COVID-19 pandemic is presenting all of us, but living with cancer during this pandemic is a challenge all to itself, a tough balancing out to pull off.

CAR T Therapy for Relapsed/Refractory DLBCL: Brian’s Story

November 25th 2020, 5:00am

By Loretta J. Nastoupil, MD, MD Anderson Cancer Center

Outdoor Nighttime Light Increasing the Risk of Non-Hodgkin Lymphoma

November 24th 2020, 10:00pm

By Colleen Moretti

We have all been told we should stay off our phone before bed, but this study proves that the outdoor light at night is truly harmful long term and could increase the risk of non-Hodgkin lymphoma.